Monograph
S01BA02 - Hydrocortisone |
Not porphyrinogenic |
NP |
Rationale
Probably insignificant systemic exposure. Substrate for CYPs 3A4, 3A7, 11 B2. Inducer and inhibitor (!) of CYP 3A4. Several references stating non-porphyrinogenicity.
Chemical description
Glucocorticoid for eye application. Glucocorticoid: South African list: use French list: authorized EPI-list: safe Merck Index: safe Kalman, Bonkowski: safe
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Softacor · Softacor 3,35 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikBelgium
Softacor · Softacor 3.35 mg/ml collyre sol. récip. unidoseUnited Kingdom
Hydrocortisone · Hydrocortisone 0.5% eye ointment · Hydrocortisone 1% eye ointment · Hydrocortisone 2.5% eye ointment · Hydrocortisone acetate · Hydrocortisone acetate 1% eye drops · Softacort · Softacort 3.35mg/ml eye drops 0.4ml unit doseDenmark
SoftacortNorway
SoftacortPoland
SoftacortLuxembourg
SoftacorIceland
SoftacortFinland
SoftacortLatvia
Hydrocortisonum · Hydrocortisonum PharmaSwissSerbia
Hydrocortison · Hydrocortison Galenika · Softacort · Softacort®
© NAPOS 2024